Adherence

Infographic: The battle for medication adherence

Infographic: The battle for medication adherence

Drugmakers and providers alike struggle to find the best tools, words, and technologies that will improve adherence rates among patients with chronic diseases.

4 reasons why patients don't fill their prescriptions

4 reasons why patients don't fill their prescriptions

Researchers still don't know why Americans who are prescribed a prescription drug to treat a chronic condition or disease so often fail to fill those prescriptions.

Five things for pharma marketers to know: Wednesday, April 12, 2017

Five things for pharma marketers to know: Wednesday, April 12, 2017

By

The FDA approves first drug to treat tardive dyskinesia; Americans use crowdfund sites to pay for prescriptions; stroke sufferers struggle with adherence

GSK and Propeller Health's smart inhaler aims to improve adherence in clinical trials

GSK and Propeller Health's smart inhaler aims to improve adherence in clinical trials

By

The drugmaker is using Propeller Health's sensor technology to find new ways to improve adherence in clinical studies.

Lilly's branded app for Trulicity looks to address adherence

Lilly's branded app for Trulicity looks to address adherence

By

Companies such as Eli Lilly and Medtronic have launched branded apps for their products, but experts say they don't make sense for all medicines.

The Science and Psychology behind Patient Engagement

The Science and Psychology behind Patient Engagement

Where are the discussions about applying proven behavior change models or the principles of adult learning and health literacy?

New mobile app seeks to address medication adherence

New mobile app seeks to address medication adherence

By

CeyHello, a newly launched social networking mobile app, tackles medication adherence by connecting patients, caregivers and family members.

Devicemakers eye market for drug adherence

Devicemakers eye market for drug adherence

By

Insulet's skin-adhesive technology is being used to improve adherence for patients taking biologics.

Five things for pharma marketers to know: Wednesday, December 2, 2015

Five things for pharma marketers to know: Wednesday, December 2, 2015

By

Negative news coverage of statins may lead people to stop taking their medication; second patient dies in Zafgen obesity drug trial; Gilead defends pricing

Five things for pharma marketers to know: Tuesday, June 9

Five things for pharma marketers to know: Tuesday, June 9

By

Study shows Merck's Januvia does not increase heart risks; a former Genentech exec launches a behavioral health business; lawmakers want black-box warnings on more opioids

WebMD to launch app for Apple's smartwatch

WebMD to launch app for Apple's smartwatch

By

The small screen makes it a user-friendly medication adherence tool.

The Delicate Human Side of Marketing Science

The Delicate Human Side of Marketing Science

For all the scientific tools that have fallen into our hands in the past few years, we are still largely falling short in our efforts to influence our audiences' behaviors.

The New Holistic Approach to Leveraging a Multi-Channel Contact Center

The New Holistic Approach to Leveraging a Multi-Channel Contact Center

Delivering smarter dynamic communications rather than static timed communications based on self-reported data can help connect patients to information and support that drive brand loyalty and program success.

Survey shows docs overestimate adherence

Survey shows docs overestimate adherence

By

A small physician survey shows doctors think their patients have higher adherence rates than the norm.

Five things for pharma marketers to know: Friday, January 30

Five things for pharma marketers to know: Friday, January 30

By

Obama's precision medicine initiative looks set for bipartisan support, Valeant has offered $296 million to buy Dendreon and researchers say Roche's Tamiflu works.

Talking, braille labels to show up in mailboxes

A CVS Health/American Council of the Blind collaboration means some visually impaired patients will soon have more engaging prescription labels.

High deductibles, costs keep patients away

High deductibles, costs keep patients away

By

More cost data for the file the latest data shows that up-front healthcare costs are prompting many patients to delay office visits.

Researchers: Pharmacy deserts contribute to access issues

Researchers: Pharmacy deserts contribute to access issues

By

Researchers studying the distribution of brick-and-mortar pharmacies in Chicago link adherence issues with geographic barriers to care.

Rate of Sovaldi non-adherence points to need for patient support

Rate of Sovaldi non-adherence points to need for patient support

By

A mélange of new treatments awaiting approval and a lack of patient support are driving down drug utilization for Gilead's HCV blockbuster, according to a new study.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.

Visual continuity key to patient adherence

Visual continuity key to patient adherence

By

Researchers at the Brigham and Women's Hospital found that continuity in color and shape have a significant impact on whether patients stick with a prescription regimen.

Key to successful digital outreach: think small

Key to successful digital outreach: think small

By

Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.

Study links patient confidence to Rx adherence

Study links patient confidence to Rx adherence

By

Researchers found a correlation between patients feeling involved and how well they stick—if they stick—to their medication regimens.

Study shows sample-drug adherence link

Study shows sample-drug adherence link

By

A survey of patients found greater prescription drug adherence among patients who received a free 30-day sample in addition to a prescription.

Study links adherence with side effect worries

A study showed that side-effect fears keep asthmatics from sticking to medication regimens.

Pitting Big Data against nonadherence

Pitting Big Data against nonadherence

By

A young company is hoping its analytics platform can help doctors and pharma figure out who's going to stop taking their medication, and get them back on track.

Another study about doctor-patient divide

Novo's global diabetes study finds that only 29% of polled patients were asked what they thought about prescribed regimens.

E-prescribing systems not so pharma friendly

E-prescribing systems not so pharma friendly

By

A study points out barriers to e-prescribing pharma products and shows how doctors rate various EHRs.

Retail pharmacies up consumer satisfaction

Retail pharmacies up consumer satisfaction

By

A study shows consumers are increasingly pleased with retail pharmacies, compared to mail order pharmacies, which are often considered a key means of driving adherence and lowering healthcare coverage costs.

Healthcare reform roundup

Healthcare reform roundup

By

A roundup of some exchange-related news circling the web.

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.